Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fight diseases.
30 employees · est. 2014 · Gaithersburg, United States
Q32 Bio Inc.
Revolutionizing the future of targeted immune therapeutics
28 employees · est. 2017 · Waltham, United States
Georgiamune Inc. is the older company (2014 vs 2017).
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Georgiamune Inc. | Q32 Bio Inc. |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2017 |
| Headquarters | ||
| Headquarters | Gaithersburg, United States | Waltham, United States |
| Employees | ||
| Employees | 30 | 28 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Unknown |
| Total Funding | ||
| Total Funding | $75.00M | $255.50M |
| Funding Rounds | ||
| Funding Rounds | 2 | 7 |
| Services | ||
| Services | Reprogramming Immune Responses, Drug Design and Development, Preclinical Research, Pipeline Development | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare Providers, Oncologists, Immunologists, Patients with Cancer, Patients with Autoimmune Diseases, Biopharmaceutical Companies | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Immune Signaling Pathways, Clinical Stage, Cancer Treatment, Autoimmune Diseases, Immune Therapeutics, Scientific Discovery, Reprogramming Immune System, Disease Fighting, Immune Balance, Biopharmaceuticals | Immune Therapeutics, IL-7 Pathway, Complement System, Autoimmune Diseases, Inflammatory Diseases, Immunotherapy, Immune System Regulation, Treatment Options, Therapeutics Development, Dysregulation, Innovative Biotech, Immune Modulation, Precision Medicine, Startup Biotech |
| Website | ||
| Website | georgiamune.com | q32bio.com |
About Georgiamune Inc.
Georgiamune Inc., founded in 2014, operates at the intersection of biotechnology, health care, and wellness. This U.S.-based clinical-stage immunotherapeutic biotechnology firm is driving innovation by reprogramming immune signaling pathways, a strategy aimed at redefining immune system responses to...
About Q32 Bio Inc.
Q32 Bio Inc. is a leading biotechnology company with a mission to revolutionize the future of targeted immune therapeutics. Established in 2017, the company is headquartered in the United States. Q32 Bio is dedicated to developing innovative therapeutics that target powerful regulators of the innate...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Georgiamune Inc. and Q32 Bio Inc. — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Georgiamune Inc. and Q32 Bio Inc. — by email.
Frequently Asked Questions
Compare Georgiamune Inc. with someone else
Start typing a company name or domain.